Pamela Frieden, LSCSW | |
141 N Main St, Haysville, KS 67060-1202 | |
(316) 200-8977 | |
(316) 524-5171 |
Full Name | Pamela Frieden |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 141 N Main St, Haysville, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295753358 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 3630 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Pamela Frieden, LSCSW 1121 W Grand Ave, Haysville, KS 67060-1259 Ph: (316) 522-9063 | Pamela Frieden, LSCSW 141 N Main St, Haysville, KS 67060-1202 Ph: (316) 200-8977 |
News Archive
Fighting hay fever with a plant extract - this works, as was shown in a clinical study conducted by researchers of the Center of Allergy & Environment of Helmholtz Zentrum München and Technische Universität München.
Lt. Governor Casey Cagle today joined Georgia Bio, the Georgia Research Alliance, the Metro Atlanta Chamber and the Innovation Crescent business community in announcing the launch of the Georgia Bioscience Commercialization Center (GBCC), which will act as a start-up catalyst and resource center for bioscience entrepreneurs in Georgia.
A study of more than 11,000 children followed for over six years has found that young children with sleep-disordered breathing are prone to developing behavioral difficulties such as hyperactivity and aggressiveness, as well as emotional symptoms and difficulty with peer relationships, according to researchers at Albert Einstein College of Medicine of Yeshiva University.
The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew Plc, highlighted the results of a multi-center study which demonstrates that gauze-based Negative Pressure Wound Therapy (NPWT) achieves many of the common treatment goals defined for foam-based NPWT systems. These goals include a reduction in wound dimension, exudate, and improvement in granulation tissue.
American Claims Evaluation, Inc. (Nasdaq: AMCE) (the "Company") today announced that on September 15, 2009, the Company received a deficiency letter from The Nasdaq Stock Market indicating that the closing bid price of its common stock had fallen below $1.00 for 30 consecutive business days, and therefore, the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2).
› Verified 6 days ago